冠心病心律失常治疗中应用稳心颗粒联合胺碘酮方案的疗效分析

Analysis of the Efficacy of Application of Wenxin Granules Combined with Amiodarone Regimen in the Treatment of Coronary Heart Disease Arrhythmia

目的 研究稳心颗粒联合胺碘酮对冠状动脉粥样硬化性心脏病(简称冠心病)心律失常的应用效果。方法 随机选取2022年6月—2023年6月内蒙古赤峰市阿鲁科尔沁旗中医医院的60例冠心病心律失常患者,按照随机数表法将其分为两组,每组30例。参照组应用胺碘酮治疗,研究组采取稳心颗粒联合胺碘酮方案。比较两组治疗效果。结果 治疗后,研究组各项血液流变学指标水平均低于参照组,差异有统计学意义(P<0.05)。治疗后,研究组缺血发生时间、发生次数均比参照组低,心律失常发生次数与持续时间低于参照组,差异有统计学意义(P<0.05)。治疗后,研究组左室收缩末期内径(38.80±3.40)mm、左室舒张末期内径(44.93±4.15)mm低于参照组,差异有统计学意义(t=2.881、4.849,P<0.05)。结论 稳心颗粒联合胺碘酮方案的应用,能够提高冠心病心律失常患者的心功能。同时,此种治疗方案有助于减少患者的缺血、心律失常发作情况,对改善其血流动力学具有重要价值。

Objective To study on the application effect of wenxin granules combined with amiodarone on arrhythmias in coronary atherosclerotic heart disease(CHD).Methods 60 patients with coronary heart disease and arrhythmia were selected from Alukerqin Banner Traditional Chinese Medicine Hospital in Chifeng City,Inner Mongolia from June 2022 to June 2023.They were randomly divided into two groups using a random number table method,with 30 cases in each group.The reference group received treatment with amiodarone,while the study group received a combination of Wenxin granules and amiodarone.Compared the therapeutic effects of two groups.Results After treatment,the levels of various hemorheological indicators in the study group were lower than those in the reference group,and the differences were statistically significant(P<0.05).After treatment,the occurrence time and frequency of ischemia in the study group were lower than those in the control group,and the occurrence and duration of arrhythmia were lower than those in the control group,the differences were statistically significant(P<0.05).After treatment,the left ventricular end systolic diameter(38.80±3.40) mm and left ventricular end diastolic diameter(44.93±4.15) mm in the study group were lower than those in the control group,the differences were statistically significant(t=2.881,4.849,P<0.05).Conclusion The application of Wenxin granules combined with amiodarone regimen can improve the cardiac function of patients with coronary arrhythmia.At the same time,this treatment program helps to reduce ischemia and arrhythmia episodes in patients,which is of great value in improving their hemodynamics.